Statistics
Publications
57
Citations
2.6K
H-Index
32
Active since
2004
Kun Cheng is an author at University of Missouri–Kansas City specializing in pharmacy, drug delivery, and medicine.
Publications per year
2004–2024
57
57
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Sashi Kandel, Pratik Adhikary, Guangfu Li et al. · Cancer Letters · 2021 · 161 citations · Full text
Medicine, Immunology, Oncology +12
Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy
Ashutosh Barve, Akshay Jain, Hao Liu et al. · Acta Biomaterialia · 2020 · 136 citations · Full text
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
Hao Liu, Zhen Zhao, Li Zhang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 129 citations · Full text
Medicine, Oncology, Pharmacology +17
TGF-β1 Gene Silencing for Treating Liver Fibrosis
Kun Cheng, Ningning Yang, Ram I. Mahato · Molecular Pharmaceutics · 2009 · 105 citations · Full text
1–5 of 57